Journals / Turkish Journal of Medical Sciences / 2002 / Cilt: 32 - Sayı: 4

Age and gender associated changes in cystatin C and Beta2-microglobulin

Pages
317–321
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, serum cysC and b 2 -microglobulin levels in healthy individuals increase with ageing, consistent with the decrease in GFR.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Assessment of renal function in clinical medicine is of great importance.
📊
Key Findings & Data:Various studies report that cystatin C (cysC) and beta 2 -microglobulin are valuable markers of renal function.
💡
Conclusion & Impact:In conclusion, serum cysC and b 2 -microglobulin levels in healthy individuals increase with ageing, consistent with the decrease in GFR.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Assessment of renal function in clinical medicine is of great importance. Various studies report that cystatin C (cysC) and beta 2 -microglobulin are valuable markers of renal function. In this study, serum cysC and beta 2 -microglobulin were measured in parallel with serum creatinine in a healthy population, and the characteristics of the relationship of cysC and beta 2 -microglobulin to age and gender were compared. Serum creatinine, cysC and b2-microglobulin were measured in 119 (86 female; 33 male, 6 to 69 years old) healthy subjects. They were divided into five different age groups: group 1 (6-15 years, n = 10), group 2 (16-30 years, n = 34), group 3 (31-45 years, n = 34), group 4 (46-60 years, n = 29) and group 5 (>61 years, n = 12). Serum creatinine did not differ among groups and was not correlated with age. Creatinine values were significantly different (p = 0.004) between males and females. CysC values differed neither by gender nor by age in the groups. However, cysC exhibited a positive correlation with age (r = 0.212, p = 0.021). b 2 -microglobulin levels showed a significant difference between groups (p = 0.036). There was a positive correlation between serum b 2 -microglobulin and age (r = 0.188, p = 0.041). In conclusion, serum cysC and b 2 -microglobulin levels in healthy individuals increase with ageing, consistent with the decrease in GFR.

🔖

Cite This Article

TURGAN, N., PARILDAR, Z., HABİF, S., BAYINDIR, O., GÜLTER, C., ÖZMEN, D., MUTAF, I. (2022). Age and gender associated changes in cystatin C and Beta2-microglobulin. Turkish Journal of Medical Sciences, Cilt: 32 - Sayı: 4, 317–321. https://ajindex.com/articles/612154

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Lindeman RD. Assessment of renal function in the old. Clin Lab Med 13:269-277, 1993
  2. Meyer BR, Bellucci A. Renal function in the elderly. Cardiol Clin 4:227-234, 1986
  3. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 38:1933-1953, 1992
  4. Payne RB. Creatinine clearance: a redundant clinical investigation. Ann Clin Biochem 23:243-250, 1986
  5. Spencer K. Analytical reviews of clinical biochemistry: the estimation of creatinine. Ann Clin Biochem 23:1-25, 1986
  6. Grubb A, Simonsen O, Storfelt G, Truedsson L, Thysell H. Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 218:499-503, 1985
  7. Schardijn GHC, Statius van Eps WE. Beta 2-microglobulin: its significance in the evaluation of renal function. Kidney" Int 32:635-641, 1987
  8. Tramonti G, Donadio C, Ferdeghini M, Annichiarico C, Norpoth M, Bianchi R, Bianchi C. Serum tumour-associated trypsin inhibitor (TAT1) and renal function. Scand J Clin Lab Invest 56:653-656, 1996
  9. Kyhse-Andersen J, Schmidt C, Nordin C, Andersson B, Nilsson-Ehle P, Lindstrom V, Grubb A. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 40:1921-1926, 1994
  10. Le Bricon T, Thervet E, Benlakehal M, Bousquet B, Legendre C, Erlich D.Le Bricon T, Thervet E. Changes in plasma cystatin C after renal transplantation and acute rejection in adults. Clin Chem 45:2243-2249, 1999
  11. Bianchi C, Donadio C, Tramonti G, Consani C, Lorusso P, Rossi G. Reappraisal of serum beta2- microglobulin as marker of GFR. Ren Fail 23:419-29, 2001
  12. Henskens YMC, Veerman ECl, Nieuw Amerongen AV. Cystatins in health and disease. Biol Chem Hoppe-Seyler 377:71-86,1996
  13. Abrahamson K, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, Hensson 0, Grubb A. Structure and expression of the human cystatin C gene. Biochem J 268:287-94, 1990
  14. Henne V, Frei P, Bürgisser P. Beta2- microglobulin- a rapid and automated determination for a broad range of clinical applications. Anticancer Res 17:2915-2918, 1997
  15. Larsen K. Creatinine assay by a reaction- kinetic approach. Clin Chim Acta 41:209-217, 1972
  16. Dunnill MS, Halley W. Some observations on the quantitative anatomy of the kidney. J Pathol 110:113-121, 1973
  17. Swan SK. The search continues- an ideal marker of GFR. Clin Ch